Skip to main content

Advertisement

Table 2 Weight and mesenchymal stem cell (MSC) dose for cats participating in the intravenous allogeneic cryopreserved MSC studies

From: Safety and efficacy of intravenous infusion of allogeneic cryopreserved mesenchymal stem cells for treatment of chronic kidney disease in cats: results of three sequential pilot studies

Study Stage Weight in kg, median (range) MSC dose in cells/kg, median (range)
Pilot study 1, n = 6 Before 4.8 (2.7 to 5.1) 4.1 × 105 (3.9 × 105 to 7.4 × 105)
After 4.8 (2.5 to 5.2)  
Pilot study 2, n = 5 Before 4.8 (4.4 to 6.2) 8.3 × 105 (6.1 × 105 to 9.1 × 105)
After 4.8 (4.2 to 7.1)  
Pilot study 3, n = 5 Before 4.8 (3.7 to 7.1) 8.4 × 105 (5.6 × 105 to 1.1 × 106)
  After 4.8 (3.5 to 7.1)